Friday, April 07, 2006

Merck & Co. Is Losing Ground Following Vioxx Ruling

A New Jersey jury awarded compensation of $4.5 million to one of the two plaintiffs in a lawsuit which claimed that Merck & Co.'s (MRK charts news Powerrating) Vioxx contributed to heart attacks. The jury rejected the other plaintiffs claims. Merck is currently trading lower by 1.57 on 7K shares Thursday morning on Inet.
Merck & Co. climbed to the upside during the later half of Wednesday morning and rose further during the final hour, to finish up by 0.51 at $35.99. The stock closed just below the upper end of a 7-week range at the highs of the year.

0 Comments:

Post a Comment

<< Home